Literature DB >> 29500107

Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders.

Priscilla Martinez1, Lars Lien2, Sarah Zemore3, Jørgen G Bramness4, Sudan Prasad Neupane5.   

Abstract

BACKGROUND: Psychological distress is common among people with a substance abuse disorder in treatment. Identifying correlates of psychological distress may serve as points of intervention to improve substance abuse treatment outcomes. Immune function measured as cytokine levels have been associated with psychological distress, but this association remains unexplored among people with a substance abuse disorder in treatment. This study aimed to examine whether cytokine levels in patients treated for a substance use disorder were related to depression, anxiety, and overall psychological distress, and to observe these associations separately among people with a past year alcohol use disorder and those with a past year drug use disorder.
METHODS: We collected cross-sectional data from 80 inpatients at five alcohol and substance abuse treatment centers in Norway. We determined alcohol and drug diagnoses, and assessed symptoms of depression, anxiety, and overall psychological distress. We tested blood samples for IL-1, IL-6, TNF-α, INF-γ, and IL-10. We used multivariate linear regressions to examine the associations between cytokine levels and psychological distress measures.
RESULTS: All cytokines were significantly and positively associated with depression score. INF-γ was significantly and negatively associated with anxiety, and IL-6 was significantly and positively associated psychological distress. Among people with only an alcohol use disorder, IL-6 was positively associated with depression and psychological distress scores, and IL-10 was negatively associated with anxiety score. Among people with only a drug use disorder, TNF-α was positively associated with depression score.
CONCLUSION: The relationship between immune function and psychological distress is robust in the context of substance abuse, and further research is warranted.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol abuse; Anxiety; Cytokines; Depression; Drug abuse; Psychological distress; Substance abuse treatment

Mesh:

Substances:

Year:  2018        PMID: 29500107      PMCID: PMC5880738          DOI: 10.1016/j.jneuroim.2018.02.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  54 in total

1.  Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment.

Authors:  Ya-Fen Chan; Michael L Dennis; Rodney R Funk
Journal:  J Subst Abuse Treat       Date:  2007-06-15

Review 2.  PTSD is associated with an excess of inflammatory immune activities.

Authors:  Jessica M Gill; Leo Saligan; Stephanie Woods; Gayle Page
Journal:  Perspect Psychiatr Care       Date:  2009-10       Impact factor: 2.186

Review 3.  The psychometric properties of the Composite International Diagnostic Interview.

Authors:  G Andrews; L Peters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-02       Impact factor: 4.328

4.  The influence of a targeted deletion of the IFNgamma gene on emotional behaviors.

Authors:  Y Kustova; Y Sei; H C Morse; A S Basile
Journal:  Brain Behav Immun       Date:  1998-12       Impact factor: 7.217

5.  Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.

Authors:  G Szabo; P Mandrekar; A Dolganiuc; D Catalano; K Kodys
Journal:  Alcohol Clin Exp Res       Date:  2001-12       Impact factor: 3.455

Review 6.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

7.  What characterizes substance abusers who commit suicide attempts? Factors related to Axis I disorders and patterns of substance use disorders. A study of treatment-seeking substance abusers in Norway.

Authors:  A S Landheim; K Bakken; P Vaglum
Journal:  Eur Addict Res       Date:  2006       Impact factor: 3.015

Review 8.  Effects of tobacco smoke on immunity, inflammation and autoimmunity.

Authors:  Yoav Arnson; Yehuda Shoenfeld; Howard Amital
Journal:  J Autoimmun       Date:  2009-12-29       Impact factor: 7.094

9.  Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity. Role of severity of depressive symptoms and alcohol consumption.

Authors:  M Irwin; C Caldwell; T L Smith; S Brown; M A Schuckit; J C Gillin
Journal:  Arch Gen Psychiatry       Date:  1990-08

10.  A prospective evaluation of the directionality of the depression-inflammation relationship.

Authors:  Jesse C Stewart; Kevin L Rand; Matthew F Muldoon; Thomas W Kamarck
Journal:  Brain Behav Immun       Date:  2009-05-04       Impact factor: 7.217

View more
  8 in total

Review 1.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

2.  Increased IL-6 expression in astrocytes is associated with emotionality, alterations in central amygdala GABAergic transmission, and excitability during alcohol withdrawal.

Authors:  Amanda J Roberts; Sophia Khom; Michal Bajo; Roman Vlkolinsky; Ilham Polis; Chelsea Cates-Gatto; Marisa Roberto; Donna L Gruol
Journal:  Brain Behav Immun       Date:  2019-08-19       Impact factor: 7.217

3.  Combining S100B and Cytokines as Neuro-Inflammatory Biomarkers for Diagnosing Generalized Anxiety Disorder: A Proof-of-Concept Study Based on Machine Learning.

Authors:  Zhongxia Shen; Lijun Cui; Shaoqi Mou; Lie Ren; Yonggui Yuan; Xinhua Shen; Gang Li
Journal:  Front Psychiatry       Date:  2022-06-22       Impact factor: 5.435

Review 4.  Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies.

Authors:  María Salud García-Gutiérrez; Francisco Navarrete; Ani Gasparyan; Daniela Navarro; Álvaro Morcuende; Teresa Femenía; Jorge Manzanares
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

5.  Sex differences in circulating inflammatory mediators as a function of substance use disorder.

Authors:  April C May; Kaiping Burrows; Leandra K Figueroa-Hall; Namik Kirlic; Evan J White; Ryan Smith; Hamed Ekhtiari; Martin P Paulus; Jonathan Savitz; Jennifer L Stewart
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.852

6.  Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.

Authors:  Yvonne Baumer; Nicole Farmer; Thomas A Premeaux; Gwenyth R Wallen; Tiffany M Powell-Wiley
Journal:  Front Public Health       Date:  2020-10-08

7.  Inflammation as the Potential Basis in Depression.

Authors:  Sung Ho Maeng; Heeok Hong
Journal:  Int Neurourol J       Date:  2019-11-30       Impact factor: 2.835

8.  Early life adversity drives sex-specific anhedonia and meningeal immune gene expression through mast cell activation.

Authors:  Natalia Duque-Wilckens; Robert Teis; Erika Sarno; Frauke Stoelting; Sonia Khalid; Zakaria Dairi; Alex Douma; Nidia Maradiaga; Stina Hench; Christine D Dharshika; Kyan M Thelen; Brian Gulbransen; A J Robison; Adam J Moeser
Journal:  Brain Behav Immun       Date:  2022-03-24       Impact factor: 19.227

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.